Kezar Life Sciences GAAP EPS of -$1.53 beats by $0.42 [Seeking Alpha]
Kezar Life Sciences, Inc. (KZR)
Last kezar life sciences, inc. earnings: 8/7 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Cash, cash equivalents and marketable securities totaled $90.2 million as of September 30, 2025, compared to $132.2 million as of December 31, 2024. The decrease was primarily attributable to cash used in operations. More on Kezar Life Sciences Seeking Alpha's Quant Rating on Kezar Life Sciences Historical earnings data for Kezar Life Sciences Financial information for Kezar Life Sciences
Show less
Read more
Impact Snapshot
Event Time:
KZR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KZR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KZR alerts
High impacting Kezar Life Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
KZR
News
- Kezar Life Sciences Reports Third Quarter 2025 Financial ResultsBusiness Wire
- Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025Business Wire
- Kezar Life Sciences (NASDAQ:KZR) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "strong sell" rating.MarketBeat
- Kezar Life Sciences (NASDAQ:KZR) had its "market perform" rating reaffirmed by analysts at William Blair.MarketBeat
- Kezar Life Sciences (NASDAQ:KZR) was given a new $5.00 price target on by analysts at Wells Fargo & Company.MarketBeat
KZR
Earnings
- 11/12/25 - Beat
KZR
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 10-Q
- 11/12/25 - Form 8-K
- KZR's page on the SEC website